$58.86 +0.34 (%) Bristol-Myers Squibb Co - NYSE

Nov. 26, 2014 | 04:00 PM

Partner Headlines

  1. A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

    GuruFocus | Nov. 24, 2014 | 13:05PM EST
  2. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  3. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  4. Blackhill Bets Almost Half of Portfolio on Williams-Sonoma

    GuruFocus | Nov. 10, 2014 | 16:00PM EST
  5. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  6. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  7. Dan Nathan Sees Unusual Options Activity In Bristol-Myers Squibb Co

    Benzinga | Oct. 31, 2014 | 07:49AM EST
  8. Lung cancer drug promising

    IBD | Oct. 30, 2014 | 19:14PM EST
  9. Bristol-Myers Lung-Cancer Drug Boosts Survival

    IBD | Oct. 30, 2014 | 11:31AM EST
  10. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  11. Eliquis revives Bristol-Myers

    IBD | Oct. 24, 2014 | 18:27PM EST
  12. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  13. Stocks Flat In Mixed Volume; Amazon.com Weighs On Techs

    IBD | Oct. 24, 2014 | 10:52AM EST
  14. UPDATE: Bristol-Myers Squibb Q3 Earnings Top Estimates

    Benzinga | Oct. 24, 2014 | 08:59AM EST
  15. Stock Futures Aim For Flat Open; Amazon.com Crumples On Q3 Miss

    IBD | Oct. 24, 2014 | 08:58AM EST
  16. #PreMarket Primer: Friday, October 24: Ebola Fears Weigh On Markets

    Benzinga | Oct. 24, 2014 | 07:47AM EST
  17. Earnings Scheduled For October 24, 2014

    Benzinga | Oct. 24, 2014 | 04:51AM EST
  18. Must Watch Stocks for Today

    Benzinga | Oct. 24, 2014 | 04:06AM EST
  19. Stocks Rebound; Amazon.com Slides After Hours

    IBD | Oct. 23, 2014 | 17:02PM EST
  20. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  21. Weekly CFO Sells Highlight: Williams Companies Inc, Google Inc, Bristol-Myers Squibb Company

    GuruFocus | Oct. 19, 2014 | 14:09PM EST
  22. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  23. Apple Leads the Charge as Earnings Season Heats Up

    FoxBusiness | Oct. 17, 2014 | 16:48PM EST
  24. The Six Types of Winning Stocks

    GuruFocus | Oct. 17, 2014 | 14:38PM EST
  25. Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level

    Benzinga | Oct. 13, 2014 | 16:57PM EST
  26. Merck to release hep C data

    IBD | Oct. 8, 2014 | 18:38PM EST
  27. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  28. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  29. Bristol-Myers pulls FDA filing

    IBD | Oct. 7, 2014 | 18:49PM EST
  30. Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo

    IBD | Oct. 7, 2014 | 11:13AM EST
  31. Bristol-Myers Squibb Statement About Asunaprevir In The US, WIthdraws NDA

    Benzinga | Oct. 7, 2014 | 08:32AM EST
  32. 2 Mutual Funds Holding Hospital Stocks

    Benzinga | Oct. 6, 2014 | 10:38AM EST
  33. NeurOp Receives Milestone Payment As Bristol-Myers Squibb Nominates NMDA Receptor Compound As Candidate For Drug Development

    Benzinga | Oct. 2, 2014 | 15:16PM EST
  34. Morgan Stanley Believes Bristol-Myers Squibb Co. Could Move Significantly Over Next Several Months

    Benzinga | Oct. 2, 2014 | 10:15AM EST
  35. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  36. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  37. Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug

    Benzinga | Sep. 5, 2014 | 16:04PM EST
  38. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  39. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD | Sep. 3, 2014 | 16:22PM EST
  40. Booming Biotech Market Benefits REIT BioMed Realty

    IBD | Sep. 2, 2014 | 17:42PM EST
  41. Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model

    GuruFocus | Aug. 29, 2014 | 11:04AM EST
  42. Bristol-Myers Drug Gets OK

    IBD | Aug. 27, 2014 | 18:56PM EST
  43. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  44. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  45. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  46. US Stock Futures Edge Higher Ahead Of Tiffany Earnings

    Benzinga | Aug. 27, 2014 | 07:07AM EST
  47. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  48. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD | Aug. 12, 2014 | 10:48AM EST
  49. Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments

    Benzinga | Aug. 11, 2014 | 16:46PM EST
  50. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
Trading Center